Skip to content
Desh Rakshak Aushdhalaya logo

Desh Rakshak Aushdhalaya

531521 BSE
₹24.50

Close ·

P/E
25.26
View as Markdown
MCP
Close 4 Nov 2026 ₹24.50 −11.20 −31.4% 1Y
Start ₹35.70

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
7.50%
Debt to Equity
0.21
EPS (TTM)
₹0.97
Book Value
₹22.83
Market Cap
—
P/E (TTM)
25.26
P/B
1.07
ROE
5.59%
Dividend Yield
0.00%
EBITDA
₹1.40 Cr
52W High
₹47.57
52W Low
₹22.45

Key Insights

Strengths

1
  • Stock is trading at 1.15 times its book value

Weaknesses

6
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 1.39% over past five years.
  • Company has a low return on equity of 5.09% over last 3 years.
  • Company has high debtors of 477 days.
  • Promoter holding has decreased over last 3 years: -14.2%
  • Working capital days have increased from 204 days to 329 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1234
OscillatorsBullish234
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
34.93
Neutral
MACD (12,26,9)
−1.05
Bearish
SMA (50)
28.20
Bearish
SMA (200)
34.98
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+3.51%
5Y+1.39%
3Y+4.67%
1Y+13.75%
TTM−24.32%

Net profit

Net profit growth by window
10Y+6.80%
5Y+5.92%
3Y+10.95%
1Y+16.67%
TTM−24.66%

Operating cash flow

Operating cash flow growth by window
10YTurned negative
5YTurned negative
3YTurned negative
1YOutflow widened by ₹1.01 Cr
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+7.16 pp
5Y+7.14 pp
3Y−1.06 pp
1Y+1.23 pp
TTM+0.12 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹5.05 Cr
Mar 2018₹5.05 Cr
Mar 2019₹5.51 Cr
Mar 2020₹5.06 Cr
Mar 2021₹6.56 Cr
Mar 2022₹6.14 Cr
Mar 2023₹6.13 Cr
Mar 2024₹5.95 Cr
Mar 2025₹6.18 Cr
Mar 2026₹7.03 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹0.28 Cr
Mar 2018₹0.28 Cr
Mar 2019₹0.34 Cr
Mar 2020₹0.30 Cr
Mar 2021₹0.42 Cr
Mar 2022₹0.48 Cr
Mar 2023₹0.41 Cr
Mar 2024₹0.43 Cr
Mar 2025₹0.48 Cr
Mar 2026₹0.56 Cr

Quarterly Results

₹ Cr
531521 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
1.11
0.84
1.58
2.49
1.08
1.19
1.88
4.39
1.3
0.95
1.4
3.45
0.83
Expenses
0.87
0.52
1.27
2.07
0.81
0.85
1.59
3.43
1.05
0.68
1.14
2.82
0.59
Operating Profit
0.24
0.32
0.31
0.42
0.27
0.34
0.29
0.96
0.25
0.27
0.26
0.63
0.24
OPM %
21.62%
38.1%
19.62%
16.87%
25%
28.57%
15.43%
21.87%
19.23%
28.42%
18.57%
18.26%
28.92%
Other Income
0
0
0.04
0
0
0
0.02
0.01
0
0
0
0.01
0
Interest
0.05
0.12
0.11
0.07
0.07
0.08
0.08
0.22
0.05
0.08
0.06
0.1
0.05
Depreciation
0.11
0.11
0.11
0.11
0.11
0.11
0.11
0.31
0.1
0.1
0.1
0.13
0.11
PBT
0.08
0.09
0.13
0.24
0.09
0.15
0.12
0.44
0.1
0.09
0.1
0.41
0.08
Tax %
0%
0%
0%
33.33%
0%
0%
0%
20.45%
0%
0%
0%
26.83%
0%
Net Profit
0.08
0.09
0.13
0.16
0.09
0.15
0.12
0.36
0.1
0.08
0.09
0.3
0.08
EPS (₹)
0.18
0.2
0.29
0.36
0.2
0.34
0.27
0.81
0.23
0.14
0.16
0.53
0.14

Profit & Loss

₹ Cr
531521 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
4.44
4.98
5.05
5.05
5.51
5.06
6.56
6.14
6.13
5.95
6.18
7.03
6.63
Expenses
3.79
4.26
4.39
4.34
4.73
4.27
5.61
4.94
4.74
4.66
4.92
5.51
5.23
Operating Profit
0.65
0.72
0.66
0.71
0.78
0.79
0.95
1.2
1.39
1.29
1.26
1.52
1.4
OPM %
14.64%
14.46%
13.07%
14.06%
14.16%
15.61%
14.48%
19.54%
22.68%
21.68%
20.39%
21.62%
21.12%
Other Income
0
0.01
0.01
0.01
0.01
0.01
0.02
0.01
−0.05
0.02
0.03
−0.1
0.01
Interest
0.12
0.11
0.11
0.13
0.13
0.16
0.16
0.24
0.42
0.37
0.31
0.31
0.29
Depreciation
0.45
0.24
0.22
0.24
0.25
0.27
0.26
0.4
0.44
0.44
0.42
0.44
0.44
PBT
0.08
0.38
0.34
0.35
0.41
0.37
0.55
0.57
0.48
0.5
0.56
0.67
0.68
Tax %
75%
23.68%
17.65%
20%
19.51%
18.92%
23.64%
15.79%
14.58%
16%
16.07%
16.42%
—
Net Profit
0.02
0.29
0.28
0.28
0.34
0.3
0.42
0.48
0.41
0.43
0.48
0.56
0.55
EPS (₹)
0.05
0.65
0.63
0.63
0.77
0.68
0.95
1.08
0.92
0.97
1.08
0.98
0.97
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
531521 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.66
4.66
4.66
4.66
4.66
4.66
4.66
4.66
4.66
4.66
4.66
5.92
Reserves
2.15
2.46
2.74
3.02
3.45
3.72
4.14
4.62
4.47
4.82
5.29
7.37
Borrowings
1.06
1.47
0.69
0.96
1.23
2.03
2.9
4.31
4.1
2.78
3.04
2.8
Other Liabilities
1.71
1.49
2.07
2.16
2.01
1.91
2.87
2.53
2.51
4.06
4.99
4.8
Total Liabilities
9.58
10.08
10.16
10.8
11.35
12.32
14.57
16.12
15.74
16.32
17.98
20.89
Fixed Assets
3.69
3.75
3.87
3.93
4.39
5.38
6.49
7.82
8.07
7.68
7.84
8.2
CWIP
1.35
2.37
2.37
2.37
2.37
2.37
2.37
2.37
2.37
2.37
1.87
1.39
Investments
0.12
0.12
0.12
0.12
0.12
0.12
0.05
0.05
0.05
0.05
0.05
0.05
Other Assets
4.42
3.84
3.8
4.38
4.47
4.45
5.66
5.88
5.25
6.22
8.22
11.25
Total Assets
9.58
10.08
10.16
10.8
11.35
12.32
14.57
16.12
15.74
16.32
17.98
20.89

Cash Flow

₹ Cr
531521 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.27
1.27
0.23
−0.15
−0.55
0.59
0.84
0.23
0.45
1.52
−0.3
−1.31
Investing
−0.45
−0.66
−0.76
0.04
0.42
−1.27
−1.26
−1.95
−0.78
−0.09
−0.02
−1.64
Financing
0
0
0
0.07
0
0.74
0.8
1.35
0.15
−1.34
0.25
3.02
Net Cash Flow
−0.18
0.61
−0.53
−0.04
−0.12
0.06
0.37
−0.36
−0.18
0.09
−0.07
0.08
Free Cash Flow
−0.24
0.2
−0.11
0.25
0.07
−0.66
−0.54
−1.51
−0.2
1.47
−0.37
−2.81
CFO/OP
42
188
44
−11
−60
84
102
27
37
124
−17
−79

Ratios

531521 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
127
125
147
179
196
221
215
236
217
315
434
477
Inventory Days
215
161
192
193
120
123
72.16
118
108
46.01
29.26
32.36
Days Payable
247
196
243
257
219
250
271
315
301
584
727
523
Cash Conversion Cycle
95.35
90.37
95.44
115
97.14
95.11
16.06
38.29
22.96
−224
−264
−13.92
Working Capital Days
180
94.55
118
149
153
162
117
164
149
109
175
329
ROCE %
2.56%
5.95%
5.4%
5.74%
6.01%
5.37%
6.42%
6.41%
7.08%
6.83%
6.89%
7.5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Desh Rakshak Aushdhalaya insights

63 extracted metrics across FY08–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 50.03%
  • Public 49.84%
  • Others 0.14%

No promoter shares pledged as of 10 Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Desh Rakshak Aushdhalaya

What does Desh Rakshak Aushdhalaya Ltd do?
Incorporated in 1901, Desh Rakshak Aushdhalaya Ltd manufactures Ayurvedic and Herbal Products
Where is Desh Rakshak Aushdhalaya Ltd (DESHRAK) listed?
Desh Rakshak Aushdhalaya Ltd trades under code 531521 on the BSE.
Which sector does Desh Rakshak Aushdhalaya Ltd belong to?
Desh Rakshak Aushdhalaya Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of Desh Rakshak Aushdhalaya Ltd?
Desh Rakshak Aushdhalaya Ltd trades at a PE ratio of 25.26 as of 4 Nov 2026, on earnings per share of ₹0.97, against a book value of ₹22.83 per share.
What is the 52-week high and low of Desh Rakshak Aushdhalaya Ltd?
Over the last 52 weeks Desh Rakshak Aushdhalaya Ltd has traded between ₹22.45 and ₹47.57 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Desh Rakshak Aushdhalaya Ltd?
Desh Rakshak Aushdhalaya Ltd reported a return on equity of 5.59%. Its debt-to-equity ratio is 0.21.

Company Information

Incorporated in 1901, Desh Rakshak Aushdhalaya Ltd manufactures Ayurvedic and Herbal Products

Website deshrakshak.in
Listed 14 Dec 2011
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531521.md for Desh Rakshak Aushdhalaya Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month